Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study.

Effect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-trial Follow-Up of SPRINT.

Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Trial.

Grand Rounds - Cheryl Anderson, PhD

Presenter: Cheryl Anderson, PhD

This is a virtual meeting. 

Science Requires Open Discourse.

Isolation and properties of bovine kidney brush border vacuolar H(+)-ATPase. A proton pump with enzymatic and structural differences from kidney microsomal H(+)-ATPase.

Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.

Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015.

Association of personality profiles with coping and adjustment to cancer among patients undergoing chemotherapy.

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses.

Direct His bundle pacing using retrograde mapping in complete heart block and L-transposition of the great arteries.

Michi Yukawa Serves as Vice-Chair of AGS Ethnogeriatrics Committee

Michi Yukawa, MD has been chosen to be the Vice-Chair of the Ethnogeriatrics Committee of the American Geriatrics Society. The Ethnogeriatrics Committee's mission is to ensure every older American receives high-quality, person-centered care by incorporating an ethnogeriatrics focus into AGS activities through participation in standing AGS Committees.

Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL.

Shuffling the deck with CTLA-4 therapy: Deep sequencing of rearranged TCRB genes demonstrates T cell repertoire remodeling in cancer patients.

Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.